Kategorie: joimax® News

joimax® Launches Numerous Innovations at EuroSpine Milan From 19 To 21 October 2011

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe/Milan, October 17th, 2011. In its anniversary year joimax® presents numerous innovations – at EuroSpine Milan for the first time, opening up the series of the big autumn congresses and exhibitions.

For the first time joimax® presents the now complete product range for endoscopic spinal surgery, showing the novel pain therapy product “Multiuse”. The new Multiuse-Set comprises instruments for endoscopic facet joint denervation or so-called rhizotomy. Subsequent to the iLESSYS® system for 360° decompression launched in spring 2011, it completes the joimax® product range that was kicked off with TESSYS® years ago. Further special blades for the successfully launched Shrill® shaver-drill resection and ablation system will be introduced to the market also.

At EuroSpine joimax® will display its complete endoscopic system of the 3rd generation with Vitegra®3 for the first time. This is the most recent generation of fully integrated documentation systems. With D-Camsource® HD LED, the first fully integrated HD camera technology with LED light source will be introduced. The joimax® proprietary radio frequency system Endovapor® will be presented to the public with new bi-polar probes.

This rapid-fire launching of a variety of new products proves again the leading position of joimax® in the field of endoscopic spinal surgery. To accompany this, joimax® offers a lunch workshop on October 20th, 2011. Congress attendees can register directly at the joimax® booth. Members of the international joimax® faculty team will present their experiences when applying the joimax® instruments, devices and surgery methods.

Further important events right after EuroSpine on the joimax® agenda are the SMISS in Las Vegas, USA, the NASS in Chicago with a big workshop to be held at the renowned Chicago Back Institute, the MEDICA in Duesseldorf, Germany, the Rome Spine Conference in Italy and finally the DWG annual congress in Hamburg early December, with another lunch symposium and an evening reception celebrating the 10th anniversary of the company.

New partnership: joimax® joins forces with JAPAN MEDICALNEXT CO., LTD.

Veröffentlicht am von christine.stump@joimax.com

(Karlsruhe-GER, 16 June 2020)

Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is starting as of now a new partnership in Japan. The distributor JMC- JAPAN MEDICALNEXT CO., LTD. and joimax® are pursuing a long-term sales cooperation that will result in an extensive distribution agreement for the entire Japanese market.

“joimax® is looking forward to working with a partner strong as JMC, says joimax® Founder and CEO Wolfgang Ries and adds, “a company that has the necessary personnel, expertise, as well as the corresponding specialization and penetration of the market”. Masayuki Yoshimura, President and CEO of JMC, explains, “We are very excited to partner with joimax®. With our shared vision for advancing the field of minimum invasive spinal surgery, we are looking forward to introducing the globally recognized joimax® products in Japan”. Thus, joimax® strengthens its sales activities in Japan and enters into another important partnership in Asia.

JAPAN MEDICALNEXT CO., LTD. founded in 1992 is located in Osaka, Japan. With 314 employees at its locations and an Orthopedics Division that will focus on joimax® products, the company is a wholly-owned entity of MC Healthcare, Inc. (subsidiary of Mitsubishi Corporation) and prominent supplier of medical devices in Japan.

SDRI appoints joimax® as exclusive distributor for Synergy Cervical Disc in Germany, Austria and Switzerland

Veröffentlicht am von christine.stump@joimax.com

TORONTO, Dec. 12, 2014 (GLOBE NEWSWIRE) — SDRI, developer of SYNERGY Disc and alternative spine technologies, enters into a five-year agreement with JOIMAX GmbH for exclusive rights to market and distribute the company’s SYNERGY family of products in Germany, Austria and Switzerland.

Karlsruhe-based Joimax, one of the leading medical device companies for minimally invasive spinal surgery, officially kicked off the alliance during an evening reception on December 11, during the 9th Annual German Spine Surgeons Meeting 2014 in Leipzig, Germany. Joimax also sponsored a luncheon symposium on December 12, where Dr. Thomas Bierstedt, and Dr. Bernd Illerhaus, both neurosurgeons from Orthopedic Neurosurgery Center (ONZ) in Datteln, shared their initial clinical experience and preliminary results utilizing the SYNERGY Disc for motion preservation procedures.

The SYNERGY Disc is the world’s first cervical disc replacement that is designed specifically to actively correct pre-operative deformity, prevent post-operative misalignment and provide optimal stability for multi-level procedures. The SYNERGY Disc incorporates a revolutionary geometry, offering multiple alignment corrections to provide surgeons with reliable and precise control of lordosis and sagittal balance.

The first clinical cases with the SYNERGY Disc were performed in 2009, in Europe. These pilot cases with the long-term, follow-up data have recently been submitted for publication.

“We are very excited with the initial results from Germany, which have validated our pilot cases,” commented SDRI’s Chief Executive Officer, Devesh Menawat. “We are eagerly anticipating the next follow-up periods and engaging in the next steps of our strategy designed to gain regulatory approval for our SYNERY Disc in the United States.”

Dr. Kemal Yucesoy, a neurosurgeon involved in the pilot study, stated: “The gold standard (cervical fusion) involves proper reconstruction of sagittal balance following decompression. Conventional disc replacements, however, do just the opposite; they restore range of motion but they have an unpredictable impact on sagittal balance. The Synergy Disc combines the best of both of these very successful treatments by restoring range of motion and normal sagittal balance to the patient. Restoring alignment of the spine is vital for long-term success of cervical disc replacements. Our long-term follow-up has demonstrated outstanding results. The SYNERGY Disc will help to expand the indications for cervical arthroplasty.”

“SDRI’s SYNERGY Disc addresses a significant unmet clinical need in patients suffering from alignment problems who, today, have no viable option,” said Wolfgang Ries, Joimax founder, chief executive officer and president. “We have begun to commercialize the product in Germany and early feedback from surgeons is very positive. We look forward to broadening the penetration for SYNERGY in German hospitals and delivering this surgical solution to doctors and hospitals in Austria and Switzerland.”

“Germany, Austria and Switzerland represent key international markets for our company,” added SDRI President Glenn Webb. “The size of these markets for spine products, combined with Joimax’s reputation for delivering relevant solutions and effective training for spine surgeons, provides us with a great opportunity for growth and to expand the adoption of our Synergy technologies into other markets. This alliance further supports our mission to give options to patients, who, otherwise, have no alternative treatments available.”

Synergy Disc is a registered trademark of SDRI. Joimax is a registered trademark of Joimax GmbH.

About Joimax GmbH.

Joimax GmbH, based in Karlsruhe, Germany, focuses on the development, production and marketing of technologies and methods of endoscopic spinal surgery. The complete Joimax systems provide the best possible visualization, tissue removal, stabilization and documentation in one, so the surgeon can work flexibly, independently and cost-effectively. The Joimax CM3, which includes surgery visitations, cadaver workshops and surgery support by experienced medical trainers and application specialists, employs a three-stage education program to train surgeons on the safe application of each specific surgery technique.

About SDRI, Inc.

Synergy Disc Replacement, Inc. (SDRI), headquartered in Toronto, Ontario, delivers alternative spinal technology solutions to solve complex surgical problems. The SDRI family of products include the SYNERGY® Cervical Disc. SYNERGY is the first and only artificial cervical disc to unite the needs for sagittal balance and motion, making it the only viable alternative to fusion in patients with pre-operative spine alignment issues.

A photo accompanying this release are available at: http://www.globenewswire.com/newsroom/prs/?pkgid=29639

Suzie Robinson, APR
Media and Investor Relations
| 214-577-9329

– See more at: http://globenewswire.com/news-release/2014/12/12/690985/10112195/en/SDRI-Appoints-JOIMAX-as-Exclusive-Distributor-for-SYNERGY-Cervical-Disc-in-Germany-Austria-and-Switzerland.html#sthash.Qxd2qOZ3.dpuf

joimax® celebrates its 10th anniversary presence with 900 users in China and reports a jump in Q1-2017 sales

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe, Germany – April 11th, 2017 – joimax®, the German based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, just celebrated its 10 years’ birthday in China with an outstanding 3 days event in Chongqing. More than 900 surgeons out of 2,000 users in China only took part in live surgeries, workshops and a scientific program on endoscopic spinal technologies including MISS fusion techniques. Besides, joimax® organized the presentation of its latest systems like the TESSYS® ISeeU and iLESSYS® Delta in product trainings as well as newest tools for endoscopic treatment in an exhibition hall. The program was supported by joimax® Faculty Members from Europe, USA and other countries. In the course of the meeting a Chinese Faculty Team with 13 members was inaugurated by Wolfgang Ries, Founder and CEO of joimax® and Qin-Guang You, President of joimax® China. ”Due to the growing education and training needs in the Asian region the time has come to form a local team for this important market”, explains Wolfgang Ries. “It is a great honor to lead this team and to support the further growth of joimax®”, says the head of the Faculty Team, Prof. Yue Zhou from the Third Military Medical University in Chongqing. He was awarded with the joimax® Handshake Award in Gold for his exceptional commitment and the members of the group received the joimax® Handshake Award in Silver.

After very satisfying growing sales figures in 2016 (31 % growth vs. 2015), joimax® is proud to announce a jump in sales in the first quarter 2017. Consolidated figures show an increase of 60 % compared to the same period of last year. “This is a very encouraging development, showing the continuing expansion and growth of the group”, states Wolfgang Ries, Founder and CEO of joimax®.

joimax® presents EndoLIF® as a world premiere at the Annual Meeting of DGNC

Veröffentlicht am von christine.stump@joimax.com

Not yet FDA cleared

joimax® presents EndoLIF® as a world premiere at the Annual Meeting of DGNC

Karlsruhe, 24 May 2013. It has become a good tradition – but this time it will include a world premiere: As in previous years, joimax® will present a lunch symposium during the 64th Annual Meeting of the German Society of Neurosurgery DGNC to be held in Düsseldorf, Germany, on 27 May 2013. As a world premiere joimax® will introduce its novel EndoLIF® system for endoscopic stabilization of the lumbar spine. The joimax® Faculty Team had the chance to see this technology during its yearly User Meeting held at the Institute of Anatomy of the University of Mainz, Germany, in April. It will now be displayed to the broad expert audience of DGNC’s Annual Meeting.

Besides the endoscopic technology for the access to the disc compartment based on the well proven TESSYS® or iLESSYS® access method, the EndoLIF® system comprises an O-cage (oblique cage) and a screw and rod system for posterior percutaneous stabilization. The advantages of this procedure are obvious:
– Smooth, atraumatic access due to dilation of tissue
– Dura and nerves are protected by the working tubes
– Dorsal bone structures are generally not affected
– O-Cage with osteo-conductive surface providing the optimum substrate for cell growth
– Stabilization via screw and rod system for percutaneous i.e. minimally invasive positioning
Indications for this procedure are the degenerative disease of intervertebral discs, mechanical instabilities and spondylolisthesis grade I and II. CE approval is expected by summer 2013.

The joimax® lunch symposium will be chaired by Prof. Dr. Jürgen Kiwit (Berlin). Dr. Guntram Krzok (Friedrichroda) will present „TESSYS® and iLESSYS® for multiple decompression therapies“. Dr. Bernd Illerhaus (Recklinghausen) will then draw the line to the EndoLIF® technology with an outlook on future therapeutic options. „The EndoLIF® system is the next logical step in the evolution of endoscopic access technologies to the spinal canal for gentle and safe minimally invasive implantation of cages with subsequent percutaneous stabilization“, states Dr. Illerhaus with conviction.

joimax® Recieves FDA Clearance to Market EndoLIF® Delta-Cage and DoubleWedge-Cage in the USA

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe (GER) — German-based joimax®, the market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is excited to announce that it has received FDA clearance to market the EndoLIF® Delta-Cage and EndoLIF® DoubleWedge-Cage in the United States. Delta-Cages and DoubleWedge-Cages are intended for intervertebral body fusion procedures for various diseases of the lumbar spine, such as degenerative disc disease.

Now in its 20th anniversary year, joimax® sets another milestone by providing a family of 3D printed titanium cages. The complete EndoLIF® product portfolio consists of the Delta-Cage, the DoubleWedge-Cage, and the O/On-Cage. All three models are designed with special features:

  • 3D printed titanium for excellent bone ingrowth, fillable with bone or bone substitute material, pre- or post-insertion
  • Anatomical shape and lordotic correction options for OLIF, TLIF, and PLIF procedures
  • “Over-the-wire” implantation for optimal targeted positioning in the intervertebral disc space
  • Endoscopic control of all surgical steps due to the EndoLIF® platform technology

“It is impressive how well these cages ensure primary stability, especially the DoubleWedge-Cage,” says Dr. Ralf Wagner, head surgeon and founder of the Ligamenta Spine Centre in Frankfurt.

Many other experts including, Dr. Florian Zentz, head surgeon of the spine center in Tutzing (Munich), Dr. Ricardo Casal Grau, orthospine surgeon from Madrid, and Dr. J. N. Alastair Gibson, spinal surgeon from Edinburgh, supported the development of the joimax® cages.

“With FDA clearance of two of our cages, our EndoLIF® platform gets more complete; the next major step in endoscopic spinal surgery is endoscopically-assisted fusion,” says joimax® Founder and CEO Wolfgang Ries. “More and more centers are proving the efficacy of these procedures in studies, demonstrating once again the major benefits of endoscopy in fusion. So far, our cages are well established in Europe and in selected centers in Asia, and now we are entering the USA, the biggest market for spinal fusion”.

joimax® turns 15 years

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe, Germany and Chicago, Illinois (April 30, 2016) – joimax®, the global acting German developer and marketer of technologies and treatment methods for minimally invasive endoscopic spinal surgery, is celebrating its 15th anniversary worldwide in 2016 starting at AANS in Chicago combined with a joimax® Senior Faculty Meeting. The aim of this meeting is to share experience, deepen expertise, specifically in reference to the newest joimax® products and applications as well as to refine the specific surgical techniques. Key topics will be centered around endoscopic treatment of degenerative spine diseases.

“When I started with the TESSYS® system in 2006 I was wondering at which patient indications this system could be applied”, says Daniel Laich, DO at Swedish Covenant Hospital in Chicago, Il.
“Now we are doing all kind of special stenotic cases and even thoracic disc, or even tumor treatments”, continues Albert Telfeian, MD, PhD at the Hasbro Hospital of The Warren Alpert Medical School at Brown University, Rhode Island.
“With the iLESSYS® Delta System I can even do an over-the-top decompression in a central stenotic patient and with the EndoLIF® method I do an endoscopic assisted stabilization if indicated” finishes Ralf Wagner, MD from the Ligamenta Spine Center in Frankfurt, Germany.

joimax®, entirely focused on treatment technologies for endoscopic minimally-invasive spinal surgery, over the years launched more than 10 different indication driven systems providing a company growth rate of over 35% per annum. To date more than 180.000 patients had been treated in over 40 countries with the various methods, based on more than 140 patents and trademarks issued globally. “The major company growth and market evolutional steps are further out in front of the companies’ future, based on solid ground with broad market adoption starting just now”, states Wolfgang Ries, CEO and founder of joimax®.

joimax® inspires Thai-German Neurosurgery Congress participants for TESSYS®

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe, 6th of October 2011. joimax® opened doors for the Thai-German Neurosurgery congress participants, under the patronage of the German Academy for Neurosurgery (GANS) and the presidency of the Director of the Clinic for Neurosurgery at the “Städtisches Klinikum” in Karlsruhe, Prof. Dr. med. Dr. h.c. Uwe Spetzger – this year taking place in Karlsruhe, South Germany.

joimax® organised a lunch symposium in line with the congress, beginning with a company conducted tour through the facility where the participants visited amongst others the departments of the technical staff, research, development and construction – the core competencies and heart of the company. Also interesting were the explanations of the company founder and managing director Wolfgang Ries speaking about the exhibits in the so called internal “museum”, documenting the development of the 10 years company history,
showing prototypes of instruments, endoscopes and devices from the founding years.

The application of TESSYS® was presented by Prof. Dr. med. Ju?rgen Kiwit, Chief Physician of the Helios Hospital for Neurosurgery in Berlin Buch, in his demonstrative lecture with many pictures and videos. “In my opinion the minimally invasive TESSYS® method is the future of spine surgery, especially when treating herniated discs and stenosis. The advantages of this gentle method are more than obvious,” he stated.

The full potential of the endoscopic spinal surgery was impressively shown by Wolfgang Ries in his overview presentation: with special instruments it is also suitable for treating e.g. spinal canal stenosis and so makes – besides the transforaminal – the interlaminar access possible also, so that the spinal canal is now accessible from all sides, meaning 360°. The instruments of the next generation with flexible forceps, reamers and endoscopes are already very advanced in the joimax® development pipeline. An endoscopic assisted spine stabilisation system will open further wide ranges of applications.

A concluding hands-on with the latest joimax® endoscopic devices on models fully convinced the 45 Thai-German guests of the company’s innovative performance.

Thai-German_Meeting2011

joimax® Organizes its First Online Endoscopic Spine Symposium

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe (GER) — joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, held its first online global symposium, “Endoscopic Spine Surgery – Indications, Technology and Limitations”, at its headquarters in the Training and Education Center (TEC) in Karlsruhe-Germany, on April 24-25, 2020.

In view of the coronavirus restrictions introduced by many governments, in March,  joimax® began holding weekly webinars, in partnership with key surgeons, to demonstrate the latest endoscopic techniques. The training sessions culminated with a two-day Symposium, full of live discussions and video demonstrations, scheduled during Western and Eastern time zones.

On April 24, joimax® Founder and CEO Wolfgang Ries, moderated a panel with faculty members Ralf Wagner, MD (Ligamenta Spine Center Frankfurt-Germany) and Christoph Hofstetter, MD, PhD (University of Washington Medicine, Neurosurgery Department, Seattle/USA). The following day, faculty member, Junseok Bae, MD (President of Wooridul Spine Hospital Seoul, South Korea), joined the panel.

On both days, the agenda included a theoretical part focused on transforaminal and interlaminar indications, and the general possibilities of endoscopy from lumbar to thoracic to cervical, as well as a hands-on lab portion. In the wet lab, Dr. Ralf Wagner demonstrated the joimax® product application of TESSYS® and iLESSYS® in specific indications. Moreover, there were presentations of Intracs® em , the first electromagnetic system for endoscopic spine applications that can navigate instruments directly at the tip. This navigation system combines lateral and AP images of the C-arm with CT scan, providing surgeons with most accurate views of the target region.

The Symposium also featured special guests: Dr. Menno Iprenburg (Iprenburg Spine Clinic, Veenhuizen, Netherlands) and Prof. Alastair Gibson (The Royal Infirmary of Edinburgh, Edinburgh Scotland); both board members of ESPINEA® Academy, who gave their valued input, based on their long-lasting experience.

“This is the  future of digital education and a great way to virtually meet and learn,” stated Dr. Iprenburg.  Prof. Gibson added, “excellent Symposium; it couldn’t get any better”.

The Symposium marked a major milestone, with 430 participants. Surgeons from all over the world joined this unique online education program and stimulating Q&A session.

When safe, joimax® will transition back to on-site workshops and trainings, but in the  meantimewill continue with its attention-grabbing online webinars.

joimax® – The experts in minimally invasive endoscopic spinal surgery show flag at the EUROSPINE in Lyon

Veröffentlicht am von christine.stump@joimax.com

Karlsruhe – joimax® is participating with an industrial exhibition at the annual meeting of the european spine society „EUROSPINE“ from October 1st to October 3rd at the Congress Center in Lyon. In Forum N° A43 the company, located in Karlsruhe, exhibits its now highly diversified product portfolio for 360° surgery in nearly all areas of the spine including endoscopic or percutaneous stabilization. In various lunch symposia, numerous european experts will show their experiences and results. During a 2 hours lunch symposium on the first day of the Congress in Hall Rhône 1 internationally recognized spine specialists under the leadership of Dr. Menno Iprenburg (Veenhuizen / Netherlands) and Dr. Alastair Gibson (Edinburgh / United Kingdom) will provide insights of their experience and into their scientific results.

Lectures on the latest product developments are expected with great interest, hereby:

  • The EndoLIF® system for endoscopic lumbar column stabilization. This system includes not only the fully endoscopic access technology to the disc space with the proven TESSYS® or iLESSYS® method, but also an implant, the so-called O-Cage (O = oblique).
  • Percusys®, an innovative screw and rod system for the posterior percutaneous stabilization.

The advantages of this methods are obvious:

  • Tissue sparing access by dilation
  • Protection of dura and nerves through a proven access corridor
  • Preservation of the posterior bony structures due to the special lateral access
  • EndoLIF® O-Cage made of Ti6Al4V for optimized bone ingrowth
  • Percutaneous stabilization by Percusys® and therefore minimally invasive

Both new systems are CE approved and the FDA approval is in progress.

Since 2004, more than 100,000 patients in 30 countries were successfully operated using the TESSYS® method and their further developments. Studies show the shorter reconvalescence time, faster recovery and thereby speed up the return of the patients to work and enhance quality of life.

Visit joimax® at EUROSPINE, Cité Internationale, Lyon Convention Centre, Forum N° A 43 and see for yourself the benefits of the new systems.